To explore the functional role of CTXN1 in glioma progression and immune response, we manipulated its expression in GL261 cells by shRNA‐mediated knockdown (shCtxn1) or overexpression (oeCtxn1) and validated the effects by qRT‐PCR (Figures 7A and S5A). The gene discussed is CTXN1; the disease is glioma.